This three-day conference, held in San Antonio, Texas, focused on the evolving landscape of headache medicine early in the year. The course addressed the “shifting paradigm” of migraine care, specifically re-evaluating long-standing beliefs about medication safety and efficacy. It offered a critical look at the comparative safety profiles of traditional therapies (like triptans) versus newer agents (CGRP inhibitors) and provided updates on integrative approaches, including the use of supplements and medical foods.
+ What You Will Learn
Attendees were able to:
Re-evaluate the cardiovascular safety profile of triptans compared to CGRP monoclonal antibodies, challenging previous assumptions about risk.
Integrate medical foods and evidence-based supplements into standard migraine treatment protocols.
Update management strategies for complex headache disorders using the latest clinical data available at the start of 2024.
Discuss the practical application of new therapeutics in a smaller, focused setting designed for direct interaction with faculty.
Network with peers to share “in-the-trenches” strategies for managing insurance barriers and patient expectations.
+ Event Details
Date: February 15 – 17, 2024
Location: Plaza San Antonio Hotel & Spa, San Antonio, Texas
Organizer: Diamond Headache Clinic Research & Educational Foundation
+ Who Should Attend
The course was designed for the interdisciplinary headache care team:
Neurologists
Primary Care Physicians (Family Practice, Internal Medicine)
Nurse Practitioners (NPs) and Physician Assistants (PAs)
Nurses
Pharmacists
+ Why Attend
Focused Curriculum: Unlike broader neurology conferences, this event provided a concentrated review of specific “paradigm shifts” in safety and efficacy that directly impact prescribing habits.
Intimate Venue: The Plaza San Antonio offered a setting conducive to networking and one-on-one discussions with key opinion leaders in headache medicine.
Integrative Focus: The inclusion of topics like “Supplements and Medical Foods” addressed the growing patient demand for holistic and non-pharmaceutical options alongside standard medical treatments.
+ Topics:
When Dizzy is Actually a Migraine
Trigeminal Autonomic Cephalalgias (TACs) and Facial Neuralgias
Tension-Type and Cervicogenic Headache Disorders
Optimization of Diagnosis and Treatment
Migraine and Dementia – 2024 Updates
Intractable Headache & Difficult Management Issues
Rare Primary Headache Disorders – We are in the Weeds of the ICHD 3
Multidisciplinary Approach to Intractable Headache Patients – 2024 Updates
Post-Traumatic Headache – Concussion & Post Concussion in Children
Indomethacin Responsive Headache Syndromes – 2024 Updates
How to Deal with Special Patients – Pearls for Success – 2024 Updates
Migraine Management 2017 vs. 2024 – Patient Dialogue Today
CGRP & the New Treatment Paradigm
Spontaneous Intracranial Hypotension (SIH) – A Recent Case
Layering Therapies – What Do We Know
Disparities in Migraine Care – 2024 Updates
Diagnosis and Management – Pediatric Migraine
Headache/Migraine in Pregnancy & Lactation
Menstrual Migraine
Perimenopause, Menopause & Migraine
New Patient Appointments in The Headache Clinic – How to Begin
Migraine Stigma
Chronic Analgesics, Comorbid Pain Disorders, and Medication Overuse Headache
Thunderclap Headache
Management of the Difficult Cluster Headache Patients – 2024 Update
Neuroimaging of Secondary Headaches and Red Flags
Supplements and Medical Food for Headaches
Devices and Blocks for Headache
Inpatient Headache Treatment – 2024 Update
A Case-Based Approach to Understanding CSF Pressure Disorders
Unraveling the Connection Between Migraine and Autonomic Dysfunction
Finding Fistulas
Medication Overuse Headache – July 2025
PACAP and Amylin in Migraine
Unmasking the Myths of Idiopathic Intracranial Hypertension
Sinus Headache – A Case
Facial Neuralgias & Trigeminal Autonomic Cephalalgias





Reviews
There are no reviews yet.